ALNY Stock Down 25% Despite Q3 Earnings Beat on Demand Growth Concerns
ALNY Stock Down 25% Despite Q3 Earnings Beat on Demand Growth Concerns Yahoo Finance
Covered in this story
Call it yourself
No calls on $ALNY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Alnylam Pharmaceuticals →Dalsna Finance is currently tracking 50 stories mentioning Alnylam Pharmaceuticals, the earliest published 10 Jul 2026.
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.